Research and Markets (http://www.researchandmarkets.com/research/65e4b4/bipolar_disorder) has announced the addition of GlobalData's new report "Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015" to their offering.
"Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015" is an essential source of information and analysis on the global bipolar disorder market. The report identifies the key trends shaping and driving the dynamism in the global bipolar disorder market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shifts in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global bipolar disorder sector.
Bipolar Disorder Market is Forecast to Show Slow Growth to 2015
The authors estimated that the global bipolar disorder market was valued at $15.9 billion in 2008 (include sales for schizophrenia) and is forecast to grow by 1.3% annually for the next seven years to reach $17.2 billion by 2015. This modest growth forecast is primarily attributed to a weak pipeline landscape. This low growth is primarily attributed to the release of generics of some of the leading products as well as weak pipeline candidates. The fact that generic invasion, a weak pipeline, a low treatment seeking rate and also the unknown cause of the disease continue to pose significant challenges for prospective market entrants, means that the market landscape in the future is expected to remain static without any significant dynamism.
Current Treatment Options are Partially Successful in Meeting Market Demands